Disclosure Panels Details Page
Head and Neck Cancers Panel - Disclosures as of 06/30/2024
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Douglas Adkins MD | Adlai-Nortye Alentis astrazeneca AstraZeneca Pharmaceuticals LP AVEO Pharmaceuticals, Inc. BeiGene BioAtla Blueprint Medicines Boehringer Ingelheim GmbH Bristol Myers Squibb Calladitis Celgene Corporation Coherus CUE Biosciences Debio Eisai Inc. Eli Lilly and Company Epizyme Exelixis Inc. Genmab Gilead Sciences, Inc. GSK Hookipa Pharma Inc Immunotep Isa Therapeutics Kura Oncology, Inc. Merck & Co., Inc. Natco Pfizer Inc. Roche Laboratories, Inc. SeaGen Surface Oncology Takeda Pharmaceuticals North America, Inc. Tizona Vaccinex Xilio |
Adlai-Nortye boerhinger ingelheim Calliditas CUE Eisai Inc. EMD Serono Exelixis Inc. Genmab Immunitas Inhibrix Jazz Pharmaceuticals Inc. Kura Oncology, Inc. Merck & Co., Inc. Merck KGaA Merus ppd Purple Biotech Regeneron Pharmactcls Rgenta SeaGen Vaccinex |
None | None | 06/18/2024 |
| Andrew Birkeland MD | None | EMD Serono | None | None | 06/04/2024 |
| Marian Birkeland PhD | None | None | None | None | 04/02/2024 |
| Nicole Blankenhorn | None | None | None | None | 03/04/2024 |
| David Brizel MD | Biomimetix | Medical malpractice case | None | Up to Date | 01/23/2024 |
| Paul Busse PhD,MD | None | None | None | None | 06/18/2024 |
| Jimmy Caudell PhD,MD | Varian Medical Systems, Inc. | EMD Serono | None | None | 06/07/2024 |
| Anthony Cmelak MD | None | None | None | None | 06/16/2024 |
| A. Dimitrios Colevas MD | AbbVie, Inc. AstraZeneca Pharmaceuticals LP Audro Biotech bioN tech Bristol Myers Squibb cue biopharma Gilead Sciences, Inc. incyte innate pharma iqvia Keyquest pds biotechnology corporation Pfizer Inc. PRA health sciences replimune tessa Threshold Pharmaceuticals viracta |
None | None | None | 02/04/2024 |
| Susan Darlow PhD | None | None | None | None | 04/17/2024 |
| Gregory Durm MD,MS | Bristol Myers Squibb Merck & Co., Inc. |
AstraZeneca Pharmaceuticals LP Curio Science Dava Oncology |
None | None | 02/06/2024 |
| Carole Fakhry MD,MPH | Merck & Co., Inc. | None | None | None | 02/02/2024 |
| Tanya Fischer MLIS,MEd | None | None | None | None | 04/22/2024 |
| Thomas Galloway MD | Cardinal Health | None | Varian Medical Systems, Inc. | None | 04/22/2024 |
| Jessica Geiger MD | Astellas Pharma US, Inc. Debio EMD Serono Genentech, Inc. Janssen Pharmaceutica Products, LP Merck & Co., Inc. Outside academic institution Regeneron Pharmaceuticals, Inc. |
Astellas Pharma US, Inc. AVEO Pharmaceuticals, Inc. EMD Serono |
None | None | 04/16/2024 |
| Maura Gillison PhD,MD | Agenus BioMimetix BioNTech AG Bristol Myers Squibb Cullinan Genentech, Inc. Genocea Biosciences Gilead Sciences, Inc. Kura Oncology, Inc. |
Adaptimmune Aptitude Health Axiom Consulting BioNtech Bristol Myers Squibb Caladrius Biosciences Coherus BioSciences Editorial Board for The Journal of Clinical Oncology EMD Serono Exelixis Inc. GSK iTeos Therapeutics LLX Solutions, LLC Merck & Co., Inc. Merus N.V. Surface |
None | None | 02/22/2024 |
| Christine Glastonbury MBBS | None | None | Elsevier | None | 06/04/2024 |
| Kristina Gregory MSN,RN | None | None | None | None | 05/27/2024 |
| Robert Haddad MD | AstraZeneca Pharmaceuticals LP Boehringer Ingelheim GmbH Bristol Myers Squibb EMD Serono Genentech, Inc. GSK Hookipa Pharma Inc ISA Kura Oncology, Inc. Merck & Co., Inc. Nanabiotix Pfizer Inc. |
AstraZeneca Pharmaceuticals LP Bayer HealthCare Boehringer Ingelheim GmbH EMD Serono GSK PDS RAPT Therapeutics Scholar Rock Vaccinex |
None | UpToDate | 06/10/2024 |
| Evelyn Handel PharmD,BCPS,BCOP | None | None | None | None | 06/18/2024 |
| Kyle Herrmann OCN,RN,BSN | None | None | None | None | 04/29/2024 |
| Erin Hesler | None | None | None | None | 05/08/2024 |
| Wesley Hicks, Jr. MD | Replimune Tactiva (start up Biotechnology Firm) |
None | None | None | 02/07/2024 |
| Ying Hitchcock MD | None | None | None | None | 06/18/2024 |
| Anne Holbrook PharmD,BCOP | None | None | None | None | 05/16/2024 |
| Antonio Jimeno PhD,MD | Bristol Myers Squibb Cantargia Debiopharma Genentech, Inc. Iovance Khar Merck & Co., Inc. Moderna sanofi-aventis U.S. SQZ |
Bluedot Bio Purple Biotech |
None | Champions Oncology, Inc.|SuviCa | 05/05/2024 |
| Aditya Juloori MD | AstraZeneca Pharmaceuticals LP EMD Serono Merck & Co., Inc. |
AstraZeneca Pharmaceuticals LP Daiichi- Sankyo Co. EMD Serono Regeneron Pharmactcls |
AstraZeneca Pharmaceuticals LP | None | 06/19/2024 |
| Michael Kase DMD | None | None | None | None | 05/24/2024 |
| Debra Leizman MD | None | None | None | None | 06/14/2024 |
| Ellie Maghami MD,FACS | None | None | None | None | 02/17/2024 |
| Loren Mell MD | AstraZeneca Pharmaceuticals LP EMD Serono Merck & Co., Inc. |
Arnold Porter Johnson & Johnson Pfizer Inc. |
None | None | 06/18/2024 |
| Bharat Mittal MD | None | None | None | None | 02/02/2024 |
| Sarah Montgomery | None | None | None | None | 01/26/2024 |
| David Pfister MD | Akeso Alx Hookipa Imvaq Kura Oncology, Inc. Meira Merck & Co., Inc. Novartis Pharmaceuticals Corporation Regeneron Pharmactcls Verastem |
None | None | None | 06/20/2024 |
| Harlan Pinto MD | None | None | None | None | 03/04/2024 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 03/13/2024 |
| Katharine Price MD | Merck & Co., Inc. | InSitu Biologics PDS Biotechnology |
None | None | 06/18/2024 |
| James Rocco MD,PhD | None | None | Regeneron Pharmaceuticals, Inc. | UPTODATE | 01/23/2024 |
| Cristina Rodriguez MD | Acerta Pharma Adagene AstraZeneca Pharmaceuticals LP Ayala Bayer HealthCare BeiGene Bristol Myers Squibb Cue Biopharma DeNovo Genentech, Inc. Incyte Corporation Kura Oncology, Inc. Merck & Co., Inc. ONCO C4 Pharmacyclics Pionyr Portola Pharmaceuticals, Inc. |
AbbVie, Inc. ADC AstraZeneca Pharmaceuticals LP BeiGene Coherus Biosciences Cue Biopharma Eisai Inc. Epizyme Genentech Incyte Corporation Karyopharm Therapeutics Kite Pharma Millennium Pharmaceuticals, Inc. NuMab Therapeutics AG Vaccitech |
None | None | 03/22/2024 |
| David Schwartz MD | None | None | None | None | 03/17/2024 |
| Jatin Shah PhD,MD | None | None | None | None | 01/30/2024 |
| David Sher MPH,MD | Varian Medical Systems, Inc. | None | None | None | 02/19/2024 |
| Sharon Spencer MD | None | None | None | None | 05/15/2024 |
| Maie St. John PhD,MD | None | None | None | None | 01/22/2024 |
| He Wang PhD,MD | None | None | None | None | 02/26/2024 |
| Gregory Weinstein MD | None | None | None | Olympus Corporation | 01/23/2024 |
| Francis Worden MD | None | Adlai Nortye Eisai Inc. Eli Lilly and Company EMD Serono Exelixis Inc. LOXO Merck & Co., Inc. PDS Biotechnology Regeneron Pharmaceuticals, Inc. Replimune Sun Pharma |
None | None | 04/16/2024 |
| Justine Yang Bruce MD | Astellas Pharma US, Inc. Cellectar Biosciences Incyte Corporation Kura Oncology, Inc. Lilly Merck & Co., Inc. SeaGen |
Kura Oncology, Inc. | None | None | 04/26/2024 |
| Sue Yom PhD,MD | Bristol Myers Squibb EMD Serono Nanobiotix |
None | None | Springer|UpToDate | 02/26/2024 |
| Weining Zhen MD | None | None | None | None | 02/13/2024 |